feed,title,long_url,short_url
Benzinga,"As CorMedix's DefenCath Moves Forward On Regulatory Path, Analyst Boosts Price Target",https://benzinga.com/general/biotech/23/05/32490786/as-cormedixs-defencath-moves-forward-on-regulatory-path-analyst-boosts-price-target,https://da.gd/ShAYH
